These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7447416)

  • 1. In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents.
    Sanders WJ; Wolinsky E
    Antimicrob Agents Chemother; 1980 Oct; 18(4):529-31. PubMed ID: 7447416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
    Wallace RJ; Dalovisio JR; Pankey GA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):611-4. PubMed ID: 526002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.
    Stone MS; Wallace RJ; Swenson JM; Thornsberry C; Christensen LA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):486-93. PubMed ID: 6651277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides.
    Wallace RJ; Wiss K
    Antimicrob Agents Chemother; 1981 Nov; 20(5):610-2. PubMed ID: 7325629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.
    Garcia-Rodriguez JA; Martin-Luengo F
    Tubercle; 1978 Dec; 59(4):277-80. PubMed ID: 726085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly growing members of the genus Mycobacterium affecting dogs and cats.
    Jang SS; Hirsh DC
    J Am Anim Hosp Assoc; 2002; 38(3):217-20. PubMed ID: 12022405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.
    Swenson JM; Thornsberry C; Silcox VA
    Antimicrob Agents Chemother; 1982 Aug; 22(2):186-92. PubMed ID: 6927280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
    Verbist L; Spaepen J; Vandepitte J
    Chemotherapy; 1976; 22(1):43-54. PubMed ID: 767065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Mycobacterium avium complex to antibacterial agents.
    Davis CE; Carpenter JL; Trevino S; Koch J; Ognibene AJ
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):149-55. PubMed ID: 3440370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution.
    Werngren J; Olsson-Liljequist B; Gezelius L; Hoffner SE
    Scand J Infect Dis; 2001; 33(8):585-8. PubMed ID: 11525351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline.
    Torres JR; Sands M; Sanders CV
    Tubercle; 1978 Sep; 59(3):193-5. PubMed ID: 705904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility pattern of Mycobacterium marinum.
    Aubry A; Jarlier V; Escolano S; Truffot-Pernot C; Cambau E
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3133-6. PubMed ID: 11036036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.
    Chazel M; Marchandin H; Keck N; Terru D; Carrière C; Ponsoda M; Jacomo V; Panteix G; Bouzinbi N; Bañuls AL; Choisy M; Solassol J; Aubry A; Godreuil S
    Ann Clin Microbiol Antimicrob; 2016 May; 15():30. PubMed ID: 27150659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ; Swenson JM; Silcox VA; Bullen MG
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM; Wallace RJ; Silcox VA; Thornsberry C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.
    Hoffner SE; Klintz L; Olsson-Liljequist B; Bolmström A
    J Clin Microbiol; 1994 Aug; 32(8):1846-9. PubMed ID: 7989530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.
    Fass RJ; Barnishan J
    Rev Infect Dis; 1980; 2(6):841-53. PubMed ID: 7012987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
    Haas H; Michel J; Sacks TG
    Chemotherapy; 1982; 28(1):1-5. PubMed ID: 7056128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.